Nxn-188

NXN-188 was developed as a dual-action oral therapeutic for the acute treatment of migraine and cluster headaches. It was designed to address the underlying causes of migraine by combining two different mechanisms of action. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Benzenebutanoic acid and 4-hydroxy-g-[4-hydroxy-3-(4-morpholinylmethyl)phenyl]-g-methyl-3-(4-morpholinylmethyl)-. Its PubChem CID is 242911.

CAS No 6634-56-6
Molecular Formula C27H36N2O6
Molecular Weight 484.6 g/mol
Synonyms 4,4-bis[4-hydroxy-3-(morpholin-4-ylmethyl)phenyl]pentanoic acid

Frequently Asked Questions